Results 191 to 200 of about 8,864 (209)
Some of the next articles are maybe not open access.

177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors

Expert Review of Gastroenterology and Hepatology, 2019
Jonathan Strosberg, Satya Das
exaly  

Clinical results of radionuclide therapy of neuroendocrine tumours with 90Y-DOTATATE and tandem 90Y/177Lu-DOTATATE: which is a better therapy option?

European Journal of Nuclear Medicine and Molecular Imaging, 2011
Alicja Hubalewska-Dydejczyk   +2 more
exaly  

Blood clearance and occupational exposure for 177Lu-DOTATATE compared to 177Lu-PSMA radionuclide therapy

Radiation and Environmental Biophysics, 2017
Nami Yeyin   +2 more
exaly  

Safety and outcomes of 177Lu-DOTATATE for neuroendocrine tumours: experience in New South Wales, Australia

Internal Medicine Journal, 2019
Enmoore Lin   +2 more
exaly  

Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study

European Journal of Nuclear Medicine and Molecular Imaging, 2020
Lisa Bodei   +2 more
exaly  

Home - About - Disclaimer - Privacy